Expert Interview
A fourth Opinion: Evaluating the potential of Nektar's Rezpegaldesleukin (IL-2 inhibitor) in patients with Alopecia Areata and Atopic Dermatitis
Ticker(s): NKTRInstitution: Indiana University School of Medicine
- Chair and associate professor of dermatlogy at Indiana University School of Medicine.
- Currently manages 100 patients with vitligo.
- Previously served as Vice-Chair for Research and Education at Tufts Medical Center, focusing on clinical trials for inflammatory disorders of the skin.
Are You Interested In These Questions?
Slingshot Insights Explained
- Call Date
- Aug 18, 2025
- Call Time
- 02:30 PM EDT
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.